5 Mark Cuban Shows How the Free Market Helps Patients - Politics Information

Mark Cuban Shows How the Free Market Helps Patients


By Sally Pipes


Billionaire investor Mark Cuban is known for his razzle-dazzle. Not only has he backed a long string of tech, media, and cryptocurrency companies, he also owns the Dallas Mavericks basketball team and is a TV star on "Shark Tank."

Getting into discount drugs might not have seemed like an obvious next move for Mr. Cuban. But that's exactly what he did last month, when he launched Mark Cuban Cost Plus Drugs.

The company's goal is to offer safe and affordable medicines at transparent prices. It's a noble cause, given that one in four Americans has trouble affording their prescriptions. Cuban has clearly observed that the inflated prices consumers pay for generic medicines are ripe for disruption. Congress should take note of his strategy.

Cost Plus offers more than 100 generic prescription medicines, many at eye-popping discounts.

Take fluoxetine, the generic equivalent of Prozac, a treatment for depression. A 30-day supply of the generic normally retails for $21.92. You can get the same thing from Cost Plus for $3.90.

A 30-count supply of the cancer drug imatinib sells for $17.10, compared to a whopping $2,502.50 at other drug stores.

The list goes on. Cost Plus requires consumers to pay for medications out of pocket and doesn't process insurance claims. But its drugs cost less than most patients would pay elsewhere even with insurance.

How are these discounts possible? Cuban isn't selling products at a loss. His company is just bypassing drug-industry middlemen and their exorbitant markups.

A new study by the Berkeley Research Group shows how steep those markups are. More than half of gross drug expenditures -- the total spent on prescription medicine at the consumer end, either by patients or their health plans -- goes to middlemen.

Those middlemen include insurers, hospitals, pharmacies, the government, and pharmacy benefit managers -- murky go-betweens who use their buying power to extract discounts from drug makers while seldom passing the savings to consumers.

The study found that the share of drug spending going to middlemen is rising. From 2013 to 2020, their portion of the intake from drug spending rose from 37% to 51%.

In other words, middlemen have been taking in more and more -- with zero benefit to consumers.

Cuban deserves credit for creating a business model that not only saves consumers money on their medicine but shows the extent to which middlemen have been ripping off patients.

For years now, Congress has debated how to rein in the predatory practices of pharmacy benefit managers, with proposed bills that would require greater transparency. But the private sector is now leading the way. Cuban's company could serve as a model and first step for fixing the price-inflated status quo.

Sally C. Pipes is President, CEO, and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute. Her latest book is False Premise, False Promise: The Disastrous Reality of Medicare for All (Encounter 2020). Follow her on Twitter @sallypipes.

More Resources


01/10/2025
Carter Funeral Brings Rare, Needed Vision of Peace


more info


01/10/2025
Three More Biden Deceptions
The president can believe what he wants to believe, and at this point, there appears to be no convincing him otherwise.

more info


01/10/2025
A Nation Suffers Whiplash Between Biden and Trump
On any other day this might seem strange

more info


01/10/2025
Biden Admin Told Us To Censor True Info


more info


01/10/2025
Facebook Admits Error--'Fact Checkers' Still Complicit
Mark Zuckerberg seems to want to reverse Facebook's censorship efforts, but those publications that participated in the program are complicit.

more info


01/10/2025
In Defense of DEI
DEI refers to three simple but important words: diversity, equity and inclusion. These three values are indispensable

more info


01/10/2025
Woke Religion Burned People's Homes to the Ground
The wildfire devastation of Los Angeles occurred largely as a result of people in power adhering blindly and madly to a very bad religion.

more info


01/10/2025
LA's Poor Communication Should Have Residents Fuming


more info


01/10/2025
Republican Party's New Ground Game


more info


01/10/2025
Opening the DNC's Black Box
Why we're publishing a previously undisclosed list of all 448 members of the Democratic National Committee

more info


01/10/2025
The Most Under-Reported Story About Biden
What was the most under-reported news story during the Biden presidency? In the last week or so, there has been a sudden burst of recognition of the extent to which Democrats and the media worked together to cover up Biden's progressing cognitive decline. One media figure after another has com

more info


01/10/2025
Biden Is No Carter
In terms of character the 46th president doesn't come close to matching the 39th.

more info


01/10/2025
Biden Says He Could've Beaten Trump. That's Delusional
Not only is Biden overestimating his political skills, he's also ungraciously insulting his vice president.

more info


01/10/2025
Dresden in Los Angeles and Our Confederacy of Dunces
LA is burning. And the derelict people responsible are worried that they are found out as charlatans and empty suits.

more info


01/10/2025
The L.A. Apocalypse Was Entirely Predictable
Today on TAP: The hills above my hometown regularly catch fire, and developers regularly build there nonetheless.

more info



Custom Search

More Politics Articles:

Related Articles

Get Ready for an American Energy Comeback


Judging from the headlines, America's energy sector could collapse at any moment. Scattered amidst coronavirus coverage are reports of plummeting energy stocks and commodities traders paying people to take barrels of oil off their hands.

Trump Administration Should Reject Foreign Prescription Drug Price Controls


In responding to the coronavirus pandemic, President Trump has rightly focused on the tremendous innovative capacity of American businesses -- first by waiving regulations that impose unnecessary burdens, next by providing incentives to get tough jobs such as vaccine development done as quickly as possible.

Clearing the Air on the EPA's Coronavirus Response


The Environmental Protection Agency (EPA) agency recently issued a memo waiving certain compliance requirements for energy firms in light of the COVID-19 outbreak. A group of House Democrats falsely claimed the EPA's memo gives oil and gas companies an "open license to pollute." To address lawmakers' concerns, the EPA has tapped an internal watchdog to review the policy. But no matter how hard they look, the investigators won't find anything close to what Democrats have suggested.

If Trump is Not Reelected, America Will Be Hurting


Most every American has an opinion about the upcoming election. However, there are several realities we must face.

For Workers' Sake, Keep the Pressure on America's Trading Partners


In his marathon testimony before Congress earlier this summer, United States Trade Representative Robert Lighthizer detailed the trade-policy achievements of President Trump's first term. It's a list that should make the administration proud.

Superbugs will Kill Millions — Unless Congress Acts


We're in the midst of the worst health crisis of the 21st century -- and it's not COVID.

Why Do We Take to the Streets?


We Americans are quick to take our disagreements to the streets. In 2020, we have claimed many causes to do so. Millions came out to protest police violence and “resist” fascism. Others “rallied” against COVID-19 lockdowns and voter fraud. We may amass crowds to evoke sympathy or provoke debate. But demonstrations aggravate and intimidate, often drawing counter protesters if not ending in violence. And even when gatherings generate debate, we are tempted to settle them by who had the larger crowd size rather than the merits of the case.

Biden Administration Must Commit to a National Pandemic Preparedness Strategy


COVID-19 has killed more than 350,000 Americans. And with case counts and hospitalizations soaring, many more deaths are sadly in store.

The FDA Can Help Patients With Rare Diseases


When I was just 18 years old, I was diagnosed with hypoparathyroidism, a rare disease that causes seizures, extreme fatigue and other life-altering complications.

A Simple Fix for Biden to Help to Make Drugs More Affordable


Americans have problems affording many drugs at pharmacies and doctors' offices. About half of those who are sick have trouble paying for their medications, according to a recent poll from the Kaiser Family Foundation.

America is Ready For a Resurrection


The followers of Jesus believed in his resurrection because they saw him alive after he was dead. They had a powerful testimony of firsthand evidence seen with their own eyes.

Small Changes to 340B Can Make a Big Difference for Struggling Patients


The Covid-19 pandemic has made the issue of healthcare access more urgent than ever. Yet, at a time of deep divisions in Washington, chances for major reform are slim.

The Need for Reconciliation is a Sign of a Bad Bill


"Budget Reconciliation" may be the most popular phrase on Capitol Hill right now. This special legislative process allows certain bills to be passed in the Senate with a simple majority so long as they impact the budget.

America was Prepared to Fight Covid-19 Thanks to Intellectual Property Rights


When Covid-19 came ashore, glaring gaps in the government's pandemic preparedness became painfully obvious. Everything from inadequate stockpiles of personal protective equipment to confusing and uncoordinated guidance regarding closures hampered our early response.

Democrats Chose the Worst Time to Revive Medicare for All


Medicare for All just won't die. More than 100 House Democrats have signed onto new legislation that would outlaw all private insurance and put all Americans on a federally-run insurance plan within two years.